21 CFR 660.30
§ 660.30 Reagent Red Blood Cells.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 660.30, § 660.30 Reagent Red Blood Cells, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88552
- Permanent ID
ys:prov:88552@1- SHA-256
46edea535949b1e432565b3b65f7345df1cecce109d2fe964dc92ade3c14f7c2
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Proper name and definition. The proper name of the product shall be Reagent Red Blood Cells, which shall consist of a preparation of human red blood cells used to detect or identify human blood-group antibodies.
(b) Source. Reagent Red Blood Cells shall be prepared from human peripheral blood meeting the criteria of §§ 660.31 and 660.32 of this chapter, or from umbilical cord cells which shall be collected and prepared according to the manufacturer's biologics license application.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.